Linden Thomas Advisory Services, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1965702
Charlotte, NC
Position in REGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,183,795
-$773,667 QoQ
Shares Held
5,106
-0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#65
of 334 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Linden Thomas Advisory Services, LLC holds $36,440,714 across 14 Biotechnology names. REGN ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
176,004 | $5,531,805 | |
| 2 | INCY |
Incyte Corp
|
46,507 | $5,272,033 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,103 | $4,025,003 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,106 | $3,183,795 | |
| 5 | EXEL |
Exelixis, Inc.
|
57,943 | $3,152,678 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
9,935 | $3,140,354 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
34,641 | $3,012,034 | |
| 8 | VCEL |
Vericel Corp
|
56,051 | $2,493,708 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,183,795 | 5,106 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,957,462 | 5,122 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $3,442,540 | 4,460 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,481,297 | 4,413 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,223,375 | 4,235 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,023,193 | 3,190 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,176,168 | 3,055 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,958,189 | 2,814 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,700,096 | 2,569 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $2,675,722 | 2,780 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,289,702 | 2,607 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,033,534 | 2,471 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $2,225,318 | 3,097 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,494,590 | 3,036 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,113,965 | 2,930 | Shares | Sole | 2023-02-17 | |
| No filing history on record for this holder in this stock. | ||||||